Tumor-bearing MMTV-NIC-PTEN+/− mice were randomised to receive vehicle (1% Tween80 in PBS; po, q.d.)or sapatinib (100 mg/kg, with 1% Tween80 in PBS; po, q.d.). This evidence concerns the gene PTEN and neoplasm.